Pancreatic Cancer Research

ResearcherNorthwell HealthActive in the last 2 years

Lyudmyla Demyan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5494-5956; OpenAlex author ID A5011445697. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: 6 papers · 2025: 3 papers · 2026: 1 paper

Papers 13

  1. Implantable Microdevices for In Vivo Assessment of Chemotherapy Response in Patient Derived Organoid Orthotopic Pancreatic Cancer Models. Co-author DOI 10.1097/sla.0000000000007071↗
  2. Evaluating the Association of Area Deprivation Index (ADI) on Postoperative Outcomes in Pancreatic Adenocarcinoma. Co-author DOI 10.1002/jso.27996↗
  3. Personalized Care for Pancreatic Cancer: Harnessing Patient-Derived Organoids. Co-author DOI 10.1007/s12029-025-01164-5↗
  4. Impact of Environmental Quality on Pancreatic Cancer Outcomes Post Pancreatoduodenectomy: A Retrospective Cohort Study. Co-author DOI 10.1007/s12029-025-01254-4↗
  5. Machine learning to predict completion of treatment for pancreatic cancer. Co-author DOI 10.1002/jso.27812↗
  6. Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer. Co-author DOI 10.1007/s00423-024-03483-w↗
  7. Comparison of neoadjuvant chemotherapy plus radiation vs. chemotherapy alone on complete pathologic response in pancreatic adenocarcinoma: an analysis of the n… First author DOI 10.1007/s44337-024-00145-0↗
  8. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability. First author DOI 10.1245/s10434-024-15129-8↗
  9. Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis Setting. Co-author DOI 10.1245/s10434-024-15352-3↗
  10. ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer Care. Co-author DOI 10.1245/s10434-024-15476-6↗
  11. Development of a Neoadjuvant Treatment Pathway to Standardize Pancreatic Cancer Care and Improve Outcomes Across a Large Diverse Health System Co-author DOI 10.1101/2023.09.19.23295749↗
  12. Advance care planning in patients undergoing surgery to resect pancreatic adenocarcinoma: Underlying tension between balancing hope and realism. Co-author DOI 10.1016/j.surg.2021.08.033↗
  13. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Co-author DOI 10.1097/sla.0000000000005558↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Oliver J. Standring · 9 shared papers, 2022–2026 · strength 1.78
  2. Daniel A. King · 9 shared papers, 2022–2026 · strength 1.78
  3. Danielle K. DePeralta · 8 shared papers, 2022–2025 · strength 1.54
  4. Shamsher Ali Pasha · 8 shared papers, 2022–2025 · strength 1.54
  5. Gary Deutsch · 6 shared papers, 2022–2024 · strength 1.16
  6. Matthew John Weiss · 6 shared papers, 2022–2024 · strength 1.16
  7. Matthew John Weiss · 5 shared papers, 2022–2025 · strength 1.05
  8. Joseph M. Herman · 6 shared papers, 2022–2024 · strength 1.00
  9. Sepideh Gholami · 4 shared papers, 2024–2026 · strength 0.93
  10. Marcovalerio Melis · 4 shared papers, 2024–2025 · strength 0.90
  11. Elliot Newman · 4 shared papers, 2024–2025 · strength 0.90
  12. Abdullah Khalid · 4 shared papers, 2024–2025 · strength 0.90
  13. Shruti Koti · 2 shared papers, 2024–2026 · strength 0.55
  14. M. Weiss · 1 shared paper, 2025 · strength 0.54
  15. John Fallon · 2 shared papers, 2024 · strength 0.38
  16. David Arthur Tuveson · 2 shared papers, 2022–2026 · strength 0.35
  17. Matthew J. Weiss · 1 shared paper, 2026 · strength 0.24
  18. Julien T. Hohenleitner · 1 shared paper, 2026 · strength 0.24
  19. Youngkyu Park · 1 shared paper, 2026 · strength 0.24
  20. Neha L. Lad · 1 shared paper, 2024 · strength 0.21
  21. Neda Amini · 1 shared paper, 2024 · strength 0.21
  22. Grace Wu · 1 shared paper, 2022 · strength 0.15
  23. Ruwan Y. Parakrama · 1 shared paper, 2023 · strength 0.15
  24. Leila T. Tchelebi · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.